BR0311590A - Agonistas de brs-3 não-peptìdicos - Google Patents

Agonistas de brs-3 não-peptìdicos

Info

Publication number
BR0311590A
BR0311590A BR0311590-9A BR0311590A BR0311590A BR 0311590 A BR0311590 A BR 0311590A BR 0311590 A BR0311590 A BR 0311590A BR 0311590 A BR0311590 A BR 0311590A
Authority
BR
Brazil
Prior art keywords
brs
agonists
peptide
compounds
relates
Prior art date
Application number
BR0311590-9A
Other languages
English (en)
Inventor
Dirk Weber
Horst Kessler
Claudia Berger
Jochen Antel
Timo Heinrich
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR0311590A publication Critical patent/BR0311590A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

"AGONISTAS DE BRS-3 NãO-PEPTìDICOS". A presente invenção refere-se a novos compostos da fórmula geral (I) com atividade agonista seletiva de BRS-3, em que A^ 1^, A^ 2^ , A^ 3^ , R^ 1^, R^ 2^, R^ 3^, Ar^ 1^, Ar^ 2^, Ar^ 3^, m e n possuem os significados definidos na descrição, bem como os medicamentos que contêm estes compostos e um processo para a preparação de compostos da fórmula (I).
BR0311590-9A 2002-06-05 2003-05-30 Agonistas de brs-3 não-peptìdicos BR0311590A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224844A DE10224844A1 (de) 2002-06-05 2002-06-05 Nicht-peptidische BRS-3-Agonisten
PCT/EP2003/005678 WO2003104196A1 (de) 2002-06-05 2003-05-30 Nicht-peptidische brs-3-agonisten

Publications (1)

Publication Number Publication Date
BR0311590A true BR0311590A (pt) 2005-05-10

Family

ID=29718840

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311590-9A BR0311590A (pt) 2002-06-05 2003-05-30 Agonistas de brs-3 não-peptìdicos

Country Status (12)

Country Link
EP (1) EP1513811B1 (pt)
JP (1) JP4594084B2 (pt)
CN (1) CN1649840A (pt)
AT (1) ATE427934T1 (pt)
AU (1) AU2003232842A1 (pt)
BR (1) BR0311590A (pt)
CA (1) CA2497609A1 (pt)
DE (2) DE10224844A1 (pt)
ES (1) ES2324709T3 (pt)
HK (1) HK1080077A1 (pt)
MX (1) MXPA04011991A (pt)
WO (1) WO2003104196A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10311984A1 (de) * 2003-03-12 2004-09-23 Freie Universität Berlin Verwendung von NEP-assoziierten Molekülen zur Behandlung von nichtimmunogenen-nichthypertensiven Zivilisationskrankheiten
GB0328796D0 (en) * 2003-12-12 2004-01-14 Biofocus Plc Compounds which interact with the G-protein coupled receptor family
AU2006285393A1 (en) * 2005-04-27 2007-03-08 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
JP2010506916A (ja) 2006-10-20 2010-03-04 メルク エンド カムパニー インコーポレーテッド ボンベシンレセプターサブタイプ３モジュレーターとしての置換イミダゾール
EP2083623A1 (en) 2006-10-20 2009-08-05 Merck & Co., Inc. Substituted imidazoles as bombesin receptor subtype-3 modulators
KR20090064458A (ko) 2006-10-20 2009-06-18 머크 앤드 캄파니 인코포레이티드 봄베신 수용체 아형-3 조절제로서의 치환된 이미다졸
US8153626B2 (en) 2006-12-11 2012-04-10 Merck Sharp & Dohme Corp. Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565568A (en) * 1995-04-06 1996-10-15 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists
EP0761220A1 (en) * 1995-08-21 1997-03-12 Eli Lilly And Company 2-Acylaminopropanamides as growth hormone secretagogues

Also Published As

Publication number Publication date
AU2003232842A1 (en) 2003-12-22
EP1513811A1 (de) 2005-03-16
JP2005535610A (ja) 2005-11-24
HK1080077A1 (zh) 2006-04-21
DE10224844A1 (de) 2004-01-08
WO2003104196A1 (de) 2003-12-18
CA2497609A1 (en) 2003-12-18
ES2324709T3 (es) 2009-08-13
MXPA04011991A (es) 2005-03-07
EP1513811B1 (de) 2009-04-08
CN1649840A (zh) 2005-08-03
JP4594084B2 (ja) 2010-12-08
ATE427934T1 (de) 2009-04-15
DE50311388D1 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
HK1088890A1 (en) Biguanide and dihydrotriazine derivatives
HK1068626A1 (en) Chemical compounds
MXPA02011370A (es) Iminoazinas substituidas.
TW200616960A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
PL363990A1 (en) Arylsulfonamides as antiviral agents
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HK1080077A1 (zh) 非肽的brs-3激動劑
DE50209545D1 (de) Flüssigkristallines medium
SE0103710D0 (sv) Compounds
BR0311386A (pt) Furancarboxamidas
UA74430C2 (uk) Похідні фенілгетероциклічних етерів як інгібітори зворотного захоплення серотоніну
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
DE60201074D1 (en) Pyrazolopyridinderivate
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
SE9904128D0 (sv) Novel compounds
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
DE602004009306D1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
ATE364594T1 (de) (4-acylaminopiperidin-1-yl)acetamide als neurokininantagonisten
WO2003104257A3 (en) PROTEASE INHIBITORS
MXPA04003478A (es) Sintesis de (4-bromofenil)(4-piperidil)metanona-(z)-o-etiloxima y sales.
MXPA03003466A (es) Derivados de piranosido.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010.